Combined Approach to Lysis Utilizing Eptifibatide and rt-PA in Acute Ischemic Stroke (CLEAR Stroke) Trial
Status:
Completed
Trial end date:
2007-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is determine the effects of using of a combination of two
drugs--integrilin (eptifibatide) and activase (recombinant tissue plasminogen activator,
rt-PA, or recombinant t-PA)--to dissolve blood clots in patients who have a stroke.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
University of Cincinnati
Collaborator:
National Institute of Neurological Disorders and Stroke (NINDS)